Bulk Manufacturer of Controlled Substances Application: Noramco, Inc., 5499 [2019-02883]
Download as PDF
<![CDATA[
5499
Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
Controlled substance
[FR Doc. 2019–02877 Filed 2–20–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 22, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on October
30, 2018, Noramco, Inc., 500 Swedes
Landing Road, Wilmington, Delaware
19801 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
DATES:
amozie on DSK3GDR082PROD with NOTICES1
Controlled substance
Marihuana .................
Tetrahydrocannabinols.
Codeine-N-oxide .......
Dihydromorphine ......
Hydromorphinol ........
Morphine-N-oxide .....
Amphetamine ...........
VerDate Sep<11>2014
Drug
code
Schedule
7360
7370
I
I
9053
9145
9301
9307
1100
I
I
I
I
II
17:08 Feb 20, 2019
Jkt 247001
Drug
code
Methylphenidate .......
Nabilone ...................
Phenylacetone ..........
Codeine ....................
Dihydrocodeine .........
Oxycodone ...............
Hydromorphone ........
Hydrocodone ............
Morphine ...................
Oripavine ..................
Thebaine ...................
Opium extracts .........
Opium fluid extract ...
Opium tincture ..........
Opium, powdered .....
Opium, granulated ....
Oxymorphone ...........
Noroxymorphone ......
Tapentadol ................
1724
7379
8501
9050
9120
9143
9150
9193
9300
9330
9333
9610
9620
9630
9639
9640
9652
9668
9780
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
bulk active pharmaceutical ingredients
(APIs) and reference standards for
distribution to their customers.
In reference to drug codes 7360
(marihuana) and 7370
(tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetics. No other activities for
these drug codes are authorized for this
registration.
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
December 7, 2018, Stepan Company,
100 W Hunter Ave, Maywood, New
Jersey 07607, re-applied to be registered
as a bulk manufacturer of the following
basic classes of controlled substances.
Controlled substance
Drug
code
Cocaine ....................
Ecgonine ...................
9041
9180
Schedule
II
II
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
[FR Doc. 2019–02883 Filed 2–20–19; 8:45 am]
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
BILLING CODE 4410–09–P
[FR Doc. 2019–02878 Filed 2–20–19; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
[Docket No. DEA–392]
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Stepan
Company
Drug Enforcement Administration
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 25, 2019. Such persons
may also file a written request for a
hearing on the application on or before
March 25, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
DATES:
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The
company listed below applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on a previously
published notice is listed below. No
comments or objections were submitted
for the notice.
SUMMARY:
E:\FR\FM\21FEN1.SGM
21FEN1
]]>Agencies
[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5499]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02883]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Noramco,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before April 22, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
October 30, 2018, Noramco, Inc., 500 Swedes Landing Road, Wilmington,
Delaware 19801 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana............................. 7360 I
Tetrahydrocannabinols................. 7370 I
Codeine-N-oxide....................... 9053 I
Dihydromorphine....................... 9145 I
Hydromorphinol........................ 9301 I
Morphine-N-oxide...................... 9307 I
Amphetamine........................... 1100 II
Methylphenidate....................... 1724 II
Nabilone.............................. 7379 II
Phenylacetone......................... 8501 II
Codeine............................... 9050 II
Dihydrocodeine........................ 9120 II
Oxycodone............................. 9143 II
Hydromorphone......................... 9150 II
Hydrocodone........................... 9193 II
Morphine.............................. 9300 II
Oripavine............................. 9330 II
Thebaine.............................. 9333 II
Opium extracts........................ 9610 II
Opium fluid extract................... 9620 II
Opium tincture........................ 9630 II
Opium, powdered....................... 9639 II
Opium, granulated..................... 9640 II
Oxymorphone........................... 9652 II
Noroxymorphone........................ 9668 II
Tapentadol............................ 9780 II
------------------------------------------------------------------------
The company plans to manufacture bulk active pharmaceutical
ingredients (APIs) and reference standards for distribution to their
customers.
In reference to drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02883 Filed 2-20-19; 8:45 am]
BILLING CODE 4410-09-P
